The company’s product line offers innovative CLIA-waived rapid tests and diagnostic instrumentation for use in physicians’ offices, clinics, hospitals, and laboratory practice settings. Point-of-care products are marketed under Jant’s registered trademarks:  Accutest®, Accustrip® and LipidPlus®.

Jant Pharmacal’s portfolio includes urine analyzers and strips, a total cholesterol and glucose test system, as well as tests for TSH, immunological fecal occult blood (iFOBT), strep A, mononucleosis, h. pylori, drugs of abuse and women’s health.

Jant Pharmacal also offers a comprehensive line of laboratory equipment, including clinical chemistry, hematology, molecular, immunoassay, urinalysis systems and reagents, as well as consultative services, to enhance laboratory efficiency and profitability.

The Spotchem EZ and Ramp200 are Jant Pharmacal Corporation’s most recent product additions. The Ramp200 is a lateral flow immunoassay platform that provides accurate and precise diagnostic information in minutes. Cardiac tests include NT-proBNP, Troponin I, CK-MB and Myoglobin. The Spotchem EZ is a benchtop chemistry analyzer that tests for a number of CLIA-Waived parameters including: Glucose, AST, ALT, Creatinine, BUN, HDL, Total Cholesterol, Triglycerides, LDL (calculated) and General Chemistry.